Therapeutic Potential of Invariant Natural Killer T Cells in Autoimmunity
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Tolerance against self-antigens is regulated by a variety of cell types with immunoregulatory properties, such as CD1d-restricted invariant natural killer T (iNKT) cells. In many experimental models of autoimmunity, iNKT cells promote self-tolerance and protect against autoimmunity. These findings are supported by studies with patients suffering from autoimmune diseases. Based on these studies, the therapeutic potential of iNKT cells in autoimmunity has been explored. Many of these studies have been performed with the potent iNKT cell agonist KRN7000 or its structural variants. These findings have generated promising results in several autoimmune diseases, although mechanisms by which iNKT cells modulate autoimmunity remain incompletely understood. Here, we will review these preclinical studies and discuss the prospects for translating their findings to patients suffering from autoimmune diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by Glycosylceramides
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., et al. (1997) · Science · doi:10.1126/science.278.5343.1626 · Cited by 2,400 · cited 1×
“A common antigen employed in the iNKT cell field is the α-galactosylceramide (α-GalCer) KRN7000, which is a synthetically optimized version of a glycolipid originally isolated from a marine sponge (6).”
Background
Cited by
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202170126 · Cited by 531
Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE
Van Kaer, L., Postoak, J. L., Wang, C., Yang, G., & Wu, L. (2019) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0221-5 · Cited by 148
Self-citationDeep immune phenotyping reveals similarities between aging, Down syndrome, and autoimmunity
Lambert, K., Moo, K. G., Arnett, A., Goel, G., Hu, A., Flynn, K. J., Speake, C., Wiedeman, A. E., Gersuk, V. H., Linsley, P. S., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abi4888 · Cited by 64
“NKT cells are autoimmunity relevant; further study of NKT dysregulation in DS may inform mechanistic studies in the typical population and clarify their role (72).”
BackgroundSharma, S. R., Choudhary, S. K., Vorobiov, J., Commins, S. P., & Karim, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1336883 · Cited by 23
Metadata
- Authors
- Van Kaer, L., & Wu, L.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-03-13
- Volume
- 9
- Pages
- 519-519
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2789724752
- Cited by
- 74
- References
- 1
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Therapeutic Potential of Invariant Natural Killer T Cells in Autoimmunity. https://app.cochat.ai/papers/10.3389/fimmu.2018.00519
- The paper
- Van Kaer, L., & Wu, L. (2018). Therapeutic Potential of Invariant Natural Killer T Cells in Autoimmunity. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2018.00519
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.